After the Public Expose, PT Sinergi Multi Lestarindo Tbk Gears Up for 2024 IPO Debut at IDX
Focus on distributing specialty chemicals for food ingredients, personal care, cosmetics, and industrial sectors, PT Sinergi Multi Lestarindo Tbk has successfully held a public expose in conjunction with the Initial Public Offering (IPO) alongside underwriter PT MNC Sekuritas at the iNews Tower on Tuesday, December 19, 2023.
During the event, CEO and Founder, Mr. Siu Min, expressed optimism about their ability to enhance expansion efforts. He further mentioned PT Sinergi Multi Lestarindo Tbk's confidence in achieving better revenue and profits in 2024, especially with 5,000 projects expected to contribute to the company's income.
Moreover, revenue will be supported by three core business segments: Food Ingredients, Personal Care and Cosmetics, and Industrial Chemicals. PT Sinergi Multi Lestarindo Tbk will consistently innovate to develop high-quality formulations, to ensure continuous growth in these three sectors.
As part of the IPO, PT Sinergi Multi Lestarindo Tbk is offering a maximum of 465,625,000 new shares, equivalent to 20% of the post-IPO issued capital, with an initial price range of Rp175 - Rp190 per share.
The target fundraising goal is Rp88,468,750,000. Some of these funds are intended for business development, specifically working capital for purchasing raw materials within the Food Ingredients, Personal Care and Cosmetics, and Industrial Chemical sectors.
The IPO proceeds will also be allocated for expanding the Research and Development (R&D) laboratory. This aims to produce a wider variety of formulations and prototypes quickly, aligned with the demands of customers and suppliers.
Here are the indications of the schedule for the initial public offering (IPO) of PT Sinergi Multi Lestarindo Tbk (SMLE):
In essence, PT Sinergi Multi Lestarindo Tbk is confident will become the premier distributor of specialty chemicals, nationally and globally.
#ptsmlIndonesia #specialtychemical #initialpublicoffering #publicexpose #IPO #SMLE